FDA Drug recall D-1031-2016
Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only
- FDA Drug
- Class III
- terminated
- Published 2016-06-22
On 2016-06-22 the FDA classified a Class III recall of Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only by Galderma Laboratories L P, citing labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1031-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-05-19 |
| Published | 2016-06-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Galderma Laboratories L P |
| Distribution | US |
Product
Doxycycline, USP Capsules 40 mg, Packaged in 30 ct Bottles, Rx Only. Marketed by: Prasco Laboratories, Mason, OH 45040 USA, Manufactured by: Catalent Pharma Solutions, LLC, Winchester, Kentucky 40391. NDC: 66993-815-30.
Reason
Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.
Identifiers
| code_info | Lot #: 1496059A, Expiry: 08/31/2017; Lot #: AD9848A, Expiry: 11/30/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1031-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.